Impact of off‐label use regulations on patient care in dermatology – a prospective study of cost‐coverage applications filed by tertiary dermatology clinics throughout Germany-Reference-Cited by-同舟云学术

Impact of off‐label use regulations on patient care in dermatology – a prospective study of cost‐coverage applications filed by tertiary dermatology clinics throughout Germany

Published:2022-07-07 Issue:11 Volume:36 Page:2241-2249
ISSN:0926-9959
Container-title:Journal of the European Academy of Dermatology and Venereology
language:en
Short-container-title:Acad Dermatol Venereol

Author:

Werner R.N.¹^ORCID,Pennitz A.¹,Eisert L.²,Schmidle P.³,Zink A.³^ORCID,Abraham S.⁴,Schäkel K.⁵,Wolff I.⁶,Goebeler M.⁷,Plange J.⁸,Sollfrank L.⁹,Zielbauer S.¹⁰¹¹,Koll P.¹²,Amschler K.¹³,Müller V.¹⁴¹⁵,Nast A.¹^ORCID

Affiliation:

1. Department of Dermatology, Venereology and Allergology, Division of Evidence‐based Medicine (dEBM) Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt‐Universität zu Berlin Berlin Germany

2. Department of Dermatology and Venereology Vivantes Klinikum Neukölln Berlin Germany

3. Department of Dermatology and Allergy Biederstein Technical University Munich, School of Medicine Munich Germany

4. Department of Dermatology Technische Universität Dresden, Carl Gustav Carus Faculty of Medicine Dresden Germany

5. Department of Dermatology University Hospital Heidelberg Heidelberg Germany

6. Department of Dermatology Universitätsklinikum Tübingen Tübingen Germany

7. Department of Dermatology, Venereology and Allergology Universitätsklinikum Würzburg Würzburg Germany

8. Department of Dermatology RWTH Aachen University Aachen Germany

9. Department of Dermatology, German Center for Immunotherapy, Deutsches Zentrum Immuntherapie Friedrich Alexander University Erlangen‐Nürnberg (FAU), Universitätsklinikum Erlangen Erlangen Germany

10. Department of Dermatology, Venereology and Allergology Goethe Universität Frankfurt am Main, Universitätsklinikum Frankfurt Frankfurt am Main Germany

11. Institute for General Practice, Evidence‐based Medicine Frankfurt Goethe Universität Frankfurt am Main, Universitätsklinikum Frankfurt Frankfurt am Main Germany

12. Department of Dermatology Universität zu Köln Köln Germany

13. Department of Dermatology University Medical Center Göttingen Göttingen Germany

14. German Cancer Research Center (DKFZ) Skin Cancer Unit Heidelberg Germany

15. Department of Dermatology, Venereology and Allergology Ruprecht‐Karl University of Heidelberg, Mannheim, University Medical Center Mannheim Mannheim Germany

Funder

Deutsche Forschungsgemeinschaft

Publisher

Wiley

Subject

Infectious Diseases,Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jdv.18357

Reference23 articles.

1. Off-label Medication Prescribing Patterns in Pediatrics: An Update

2. Use of off-label and unlicensed medicines in neonatal intensive care

3. Off label prescribing to children in primary care in Germany: retrospective cohort study

4. Off-label medicine use in children and adolescents: results of a population-based study in Germany

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. [Artículo traducido] Perfil de seguridad a largo plazo y usos fuera de indicación de los inhibidores de JAK en dermatología;Actas Dermo-Sifiliográficas;2023-10

2. Long-Term Safety Profile and Off-Label Use of JAK Inhibitors in Dermatological Disorders;Actas Dermo-Sifiliográficas;2023-10